Q: 34 years old male who recently migrated from Brazil is admitted to the ICU with a mental status change. Initial workup showed hypereosinophilic syndrome (HES) with absolute eosinophil count (AEC) above 100 x 109/L. High-dose glucocorticoids is decided as an immediate management. Which one of the underlying diseases needs to be ruled out?
Answer: strongyloidiasis
Strongyloidiasis needs to be ruled out in patients from highly endemic areas. Glucocorticoids may precipitate potentially fatal dissemination, causing hyperinfection syndrome. Ideally, these patients should be treated with ivermectin (200 mcg/kg daily) for two days prior.
In patients who need urgent treatment, like the patient in the above question with organ involvement, ivermectin may be given concomitantly with glucocorticoids. In fact, all at-risk patients should be treated, even if the serology is negative, as serology is not a reliable test, and stool examination for larvae is also insensitive.
Glucocorticoids accelerate the apoptosis and/or sequestration of eosinophils.
#ID
#hematology
References:
1. Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024 May;99(5):946-968. doi: 10.1002/ajh.27287. Epub 2024 Mar 29. PMID: 38551368.
2. Simon HU, Klion A. Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol. 2012 Apr;49(2):160-70. doi: 10.1053/j.seminhematol.2012.01.002. PMID: 22449626; PMCID: PMC3314228.
3. Khadka P, Khadka P, Thapaliya J, Karkee DB. Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease. JMM Case Rep. 2018 Sep 11;5(9):e005165. doi: 10.1099/jmmcr.0.005165. PMID: 30425838; PMCID: PMC6230759.
4. Domínguez VR, Pérez-López C, Sánchez CV, Contreras CU, Guerrero AI, Abenza Abildúa MJ. Strongyloides hyperinfection syndrome due to corticosteroid therapy after resection of meningioma: illustrative case. J Neurosurg Case Lessons. 2022 Jul 11;4(2):CASE21667. doi: 10.3171/CASE21667. PMID: 35855010; PMCID: PMC9274291.